Health
Antibiotice Iasi Seeks to Distribute RON2.2M as Dividends
Romanian state-owned Antibiotice Iasi (ATB.RO), the largest pharmaceutical producer in Romania, plans to distribute RON2.2 million as dividends from its 2020 profit of RON26 million profit.
UK’s Novator Pharma Set to Invest EUR13M in Romania
Novator Pharma SRL, which has been operating in Romania since 2018, has got its EUR4.8 million state aid application granted for an investment almost three times that amount, EUR13.7 million...
Regina Maria Becomes Private Medical Services Market Leader, CEO Says
Private medical services network Regina Maria, owned by investment fund Mid Europa Partners, reported a consolidated turnover of EUR237 million in 2020, up 27% on the year.
Medical Lab Divisions of MedLife and Medicover Generate 20% to 50% of Group Revenue
The private medical labs of two leading health care providers in Romania – market leader MedLife and Medicover, the third leading operator, generated significant revenue for the groups they...
MedLife Completes Acquisition of Veridia Medical Center in Bucharest
MedLife (M.RO), the leader of the private medical services market in Romania, said Friday it has completed the acquisition of the Veridia Medical Center in Bucharest, known as Basarab Medica...
Zentiva Climbs to Third Place Among Pharmaceutical Companies by Sales in Romania in 2020
The strategy adopted at the onset of the pandemic to boost production capacity for drugs in demand drove local pharmaceutical manufacturer Zentiva to third place among the largest pharmaceut...
MedLife Posts 246% Growth in Net Profit in 2020, to RON62M
MedLife Group (M.RO), the leader of the private medical services market in Romania, on Friday reported a net profit of RON62 million for 2020, up 246% compared with 2019.
Antibiotice Iasi Net Profit Drops 16% in 2002, to RON25M
Antibiotice Iasi (ATB.RO), the largest pharmaceutical producer in Romania, on Thursday reported a 16% drop in net profit in 2002, to RON25 million.
Dermo-Cosmetics Sales in Romania Down 2.7% in 2020, to RON261.9M
Romanians bought RON261.9 million (EUR54.1 million) worth of dermo-cosmetics at retail prices in 2020, down 2.7% compared with 2019, a market report by Cegedim Customer showed Wednesday.